Brinker Capital Investments’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.86M | Sell |
24,477
-2,713
| -10% | -$929K | 0.07% | 251 |
|
|
2026
Q1 | $9.57M | Sell |
27,190
-4,182
| -13% | -$1.49M | 0.08% | 215 |
|
|
2025
Q4 | $10.3M | Buy |
31,372
+1,910
| +6% | +$606K | 0.08% | 243 |
|
|
2025
Q3 | $8.31M | Sell |
29,462
-1,488
| -5% | -$432K | 0.06% | 278 |
|
|
2025
Q2 | $8.64M | Sell |
30,950
-809
| -3% | -$229K | 0.07% | 258 |
|
|
2025
Q1 | $9.89M | Buy |
31,759
+3,745
| +13% | +$1.11M | 0.1% | 204 |
|
|
2024
Q4 | $7.3M | Sell |
28,014
-571
| -2% | -$169K | 0.07% | 248 |
|
|
2024
Q3 | $9.21M | Sell |
28,585
-85
| -0.3% | -$27.8K | 0.09% | 216 |
|
|
2024
Q2 | $8.96M | Buy |
28,670
+1,088
| +4% | +$320K | 0.09% | 205 |
|
|
2024
Q1 | $7.84M | Sell |
27,582
-1,703
| -6% | -$498K | 0.08% | 240 |
|
|
2023
Q4 | $9.1M | Buy |
29,285
+3,533
| +14% | +$963K | 0.11% | 193 |
|
|
2023
Q3 | $6.92M | Buy |
25,752
+1,825
| +8% | +$455K | 0.08% | 228 |
|
|
2023
Q2 | $5.31M | Sell |
23,927
-8,352
| -26% | -$1.94M | 0.06% | 317 |
|
|
2023
Q1 | $7.8M | Buy |
32,279
+10,265
| +47% | +$2.52M | 0.1% | 192 |
|
|
2022
Q4 | $5.78M | Sell |
22,014
-2,056
| -9% | -$551K | 0.12% | 182 |
|
|
2022
Q3 | $5.42M | Sell |
24,070
-1,006
| -4% | -$244K | 0.11% | 177 |
|
|
2022
Q2 | $6.1M | Sell |
25,076
-2,912
| -10% | -$714K | 0.12% | 175 |
|
|
2022
Q1 | $6.77M | Buy |
27,988
+1,002
| +4% | +$230K | 0.1% | 188 |
|
|
2021
Q4 | $6.07M | Buy |
26,986
+9,905
| +58% | +$2.09M | 0.09% | 232 |
|
|
2021
Q3 | $4.16M | Hold |
17,081
| – | – | 0.07% | 311 |
|
|
2021
Q2 | $4.16M | Buy |
17,081
+1,808
| +12% | +$445K | 0.06% | 357 |
|
|
2021
Q1 | $3.8M | Sell |
15,273
-4,808
| -24% | -$1.15M | 0.06% | 315 |
|
|
2020
Q4 | $4.62M | Buy |
20,081
+1,273
| +7% | +$293K | 0.07% | 333 |
|
|
2020
Q3 | $4.78M | Buy |
+18,808
| New | +$4.66M | 0.08% | 255 |
|
|
2020
Q1 | – | Sell |
-157
| Closed | -$38K | – | 323 |
|
|
2019
Q4 | $38K | Buy |
157
+100
| +175% | +$22K | ﹤0.01% | 444 |
|
|
2019
Q3 | $11K | Sell |
57
-696
| -92% | -$134K | ﹤0.01% | 559 |
|
|
2019
Q2 | $139K | Buy |
753
+428
| +132% | +$76.6K | ﹤0.01% | 436 |
|
|
2019
Q1 | $62K | Buy |
325
+307
| +1,706% | +$58.6K | ﹤0.01% | 427 |
|
|
2018
Q4 | $4K | Hold |
18
| – | – | ﹤0.01% | 560 |
|
|
2018
Q3 | $4K | Buy |
+18
| New | +$3.55K | ﹤0.01% | 536 |
|
|
2017
Q4 | – | Sell |
-15
| Closed | -$3K | – | 508 |
|
|
2017
Q3 | $3K | Buy |
15
+9
| +150% | +$1.59K | ﹤0.01% | 517 |
|
|
2017
Q2 | $1K | Buy |
+6
| New | +$976 | ﹤0.01% | 465 |
|
|
2017
Q1 | – | Sell |
-40
| Closed | -$6K | – | 459 |
|
|
2016
Q4 | $6K | Buy |
+40
| New | +$6.02K | ﹤0.01% | 417 |
|
|
2016
Q1 | – | Sell |
-4
| Closed | -$1K | – | 409 |
|
|
2015
Q4 | $1K | Buy |
+4
| New | +$629 | ﹤0.01% | 485 |
|
|
2015
Q1 | – | Sell |
-600
| Closed | -$96K | – | 424 |
|
|
2014
Q4 | $96K | Buy |
+600
| New | +$93.5K | ﹤0.01% | 288 |
|
Other funds holding AMGN
Brinker Capital Investments's AMGN Position: Q2 2026 in Review
Brinker Capital Investments reduced its Amgen (AMGN) stake by 10% in Q2 2026, selling an estimated $929K and leaving 24,477 shares worth $8.86M. The position accounts for 0.07% of the portfolio, ranked #251.
Brinker Capital Investments first reported a position in AMGN in Q4 2014 and has held it in 35 quarters since. The position peaked at $10.3M in Q4 2025. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Brinker Capital Investments held 24,477 shares of Amgen worth $8.86M as of Q2 2026.
- Brinker Capital Investments sold 2,713 Amgen shares in Q2 2026, an estimated $929K.
- Amgen made up 0.07% of Brinker Capital Investments's portfolio in Q2 2026, its #251 holding.
- Brinker Capital Investments first reported a position in Amgen in Q4 2014 and has held it in 35 quarters since.
- Brinker Capital Investments's Amgen position peaked at $10.3M in Q4 2025.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.